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Abstract. Introduction: Evidence suggests that the cerebellum could play a role 
in the pathophysiology of orthostatic tremor. The link between orthostatic tremor 
and the cerebellum is of interest, especially in light of the role the cerebellum 
plays in cognition, and it raises the possibility that orthostatic tremor patients 
could have cognitive deficits consistent with cerebellar dysfunction. Our aim was 
to examine whether orthostatic tremor patients had cognitive deficits and distinct 
personality profiles when compared with matched controls. 
Methods: Sixteen consecutive orthostatic tremor patients (65.7±13.3 years) and 
32 healthy matched controls underwent a neuropsychological battery and the 
Personality Assessment Inventory. In linear regression models, the dependent 
variable was each one of the neuropsychological test scores or the Personality 
Assessment Inventory subscales and the independent variable was orthostatic 
tremor vs. control.  
Results: Adjusted for age in years, sex, years of education, comorbidity index, 
current smoker, and depressive symptoms, diagnosis (orthostatic tremor  vs. 
healthy control) was associated with poor performance on tests of executive 
function, visuospatial ability, verbal memory, visual memory, and language 
tests, and on a number of the Personality Assessment Inventory subscales 
(somatic concerns, anxiety related disorders, depression, and antisocial 
features). Older-onset OT (>60 years) patients had poorer scores on cognitive 
and personality testing compared with their younger-onset OT counterparts.  
Conclusion: Orthostatic tremor patients have deficits in specific aspects of 
neuropsychological functioning, particularly those thought to rely on the integrity 
of the prefrontal cortex, which suggests involvement of frontocerebellar circuits. 
Cognitive impairment and personality disturbances could be disease-associated 




























Orthostatic tremor (OT), also known as ‘shaky legs syndrome’,[1] is an 
enigmatic and rare condition characterized by unsteadiness while standing still, 
and relieved upon sitting down or walking; it is thought to arise from a central 
generator in the cerebellum or brainstem.[2, 3] OT may be a family of diseases, 
unified by the presence of regular, rapid lower limb tremor when standing, but 
further characterized by etiological and clinical heterogeneity.[3] OT may be 
idiopathic or secondary (symptomatic). Gerschlager et al.[4] suggested the 
subdivision of OT into two broad groups - those with “primary OT” with or without 
postural arm tremor, and those with “OT plus,” in whom there are additional 
associated movement disorders, mainly parkinsonism. 
There is some evidence that suggests an important role of the cerebellum 
in the pathophysiology of OT. First, a small number of symptomatic OT cases 
have cerebellar atrophy.[5, 6] Second, one positron emission tomography study 
of four OT patients revealed bilateral activation of the cerebellar hemispheres as 
well as activation of the cerebellar vermis, thalamus, and lentiform nucleus.[7] 
Third, posturographic data from OT patients are indistinguishable from those 
seen in patients with cerebellar diseases.[8] 
The link between OT and the cerebellum is of interest, especially in light 
of the role the cerebellum plays in cognition,[9] and it raises the possibility that 
OT patients could have cognitive deficits consistent with cerebellar dysfunction. 
However, detailed neuropsychological assessment in these patients has not 
previously been reported. In addition, there is considerable evidence from 
epidemiological and clinical studies that shows a consistent impact of other 
tremor disorders, such as essential tremor or Parkinson’s disease, on cognition 
as well as other higher functions (e.g., personality)[10-12] Given these 
observations, we hypothesized that cognition and personality could be affected 
in OT. To investigate the possibility that OT patients have cognitive deficits and 
personality problems, we evaluated neuropsychological test performance, and 
psychopathology and personality symptoms in a consecutive cohort of OT 




OT patients were consecutively recruited from December 2011 to May 2013 
from the outpatient neurology clinics of the University Hospital “12 de Octubre” in 
Madrid (Spain), a public hospital, which covers an area of more than 400,000 
inhabitants. Four neurologists with expertise in movement disorders (J.B.-L., 
J.P.R., M.M., and A.S.-F.), examined these patients, who were referred to the 
outpatient neurology clinics with a subjective feeling of unsteadiness when 
standing, which was absent while walking, seated or supine. The neurological 
examination comprised a general neurological examination and the motor portion 
of the Unified Parkinson’s Disease Rating Scale (m-UPDRS).[13] Mild 
parkinsonian signs were defined as present when any one of the following 
conditions was met: (1) two or more m-UPDRS[13] ratings = 1; or (2) one m-
UPDRS[13] rating = 2; or (3) the m-UPDRS rest tremor rating = 1. Diagnoses of 
OT were assigned by the four neurologists using the Consensus Statement on 
Tremor by the Movement Disorder Society [14], that is, a suggestive clinical 
picture of OT (subjective feeling of unsteadiness while standing without problems 
when sitting and lying, and sparse clinical findings that are mostly limited to a 
visible and occasionally only palpable fine amplitude rippling of the leg muscles 
when standing) that is confirmed by electromyogram (EMG) recordings (i.e., 
synchronized leg tremor present only on standing). A senior neuropsychologist 
(V.P.), specializing in cognitive problems associated with movement disorders, 
performed a mental status examination on each patient and control, applying 
DSM–IV criteria and excluding those persons who had dementia. Also excluded 
were those who could not complete the neuropsychological evaluations. 
Of 21 eligible OT patients, five were excluded from the final cohort. One 
92-year-old woman with OT was excluded because she could not complete the 
neuropsychological testing due to her advanced age; another 81 year-old 
woman with OT suddenly died just before neuropsychological testing; and two 
women (80 and 92 years) and one 66-year old man with OT refused to undergo 
the neuropsychological testing. No healthy control was excluded due to 
incomplete neuropsychological evaluation or refusal. No participants were 
excluded because of major acute comorbidities or dementia. 
OT patients were 1:2 frequency-matched with healthy controls. Frequency-
matching was based on age and years of education. 
      Healthy controls were relatives or friends of the health professionals 
working at the University Hospital “12 de Octubre” of Madrid (Spain) or relatives 
of patients who came to the neurological clinics for reasons other than OT (e.g., 
headache, dizziness). None reported having a first-degree or second-degree 
relative with OT or essential tremor. Each control was examined by two 
neurologists (J.P.R. and A.S.-F.), to further rule out any neurological conditions, 
and by a neuropsychologist, as noted above. 
Procedure 
During recruitment, patients and controls were told that the purpose of the 
study was to complete a testing battery to assess neuropsychological and 
personality status. After the study had been described to participants, informed 
consent to participate was obtained. Clinical characteristics were obtained from 
review of records from their outpatient neurological care. All of the 
neuropsychological and personality tests were performed on the same day by the 
same examiner (V.P.). All participants underwent a neuropsychological 
assessment of cognitive functioning, including attention and cognitive processing 
speed, executive function, visuospatial ability, verbal memory, visual memory, 
language, and mood (Table 1). The tests chosen for the battery attempted to 
make minimal demands on motor processes in order to avoid effects of any hand 
tremor.  
To evaluate attention, participants underwent the Direct Digit Span and the 
Coding-Digit Symbol subtests from the Wechsler Adult Intelligence Scale - Third 
Edition (WAIS) (higher scores indicate better cognitive performance).[15] First, the 
examinee is required to repeat 3-9 digits forward (direct).[15] Second, the 
numbers 1-7 have to be paired with symbols on a key presented to the  
examinee.[15]  
Executive function was evaluated with a series of tests. First, the Stroop 
Color–Word Trial is a test that requires participants to inhibit a natural response 
(reading a word) and replace it with another response (saying a color).[16] 
Participants completed 45-second word naming, color naming, and color–word 
naming trials of a computer-based Stroop task.[16] The score for this study was 
the number of correct responses in the color–word trial.[16] Second, the 
Wisconsin Card Sorting Test, a test of “set-shifting”, requires the examinee to 
discern the sort criterion of a set of cards based upon “correct” versus “incorrect” 
feedback given by the examiner.[17] The score for this study was the number of 
errors and perseverations (higher scores indicate worse performance).[17] Third, 
the Similarities subtest from the WAIS-III was administered;[15] in this test, which 
examines concrete, functional, and abstract concept formation, 19 items require 
the examinee to describe how two items are alike.[15] Higher scores indicate 
better cognitive performance.[15] Fourth, the Indirect Digit Span subtest from the 
WAIS-III was administered.[15] In this subtest that measures working memory, 
the examinee is required to repeat 2-9 digists backwards (indirect). Higher scores 
indicate better cognitive performance.[15] Fifth, the Controlled Oral Word 
Association Test (COWAT), a test that measures phonetic fluency, was 
administered.[18] Participants are provided three letters of the alphabet (F, A, 
and S), one letter at a time, and instructed to provide as many words as possible 
that begin with this letter in a 60-second interval.[18] Higher scores indicate better 
cognitive performance.[18] Sixth, the Tower of London was administered, a well-
known test used for the assessment of executive function, specifically to detect 
deficits in planning.[19] The test consists of two boards with pegs and several 
beads with different colors.[19] The examiner uses the beads and the boards to 
present the examinee with problem-solving tasks.[19] For this study, we recorded 
the time required to execute the test.[19] Finally, the Frontal Assessment Battery, 
a brief tool, designed to assess frontal lobe functions, including conceptualization, 
mental flexibility, motor programming, sensitivity to interference, inhibitory 
control, and environmental autonomy, was administered.[20] 
To evaluate visuospatial ability, two tests were used. The first, the Benton 
Judgment of Line Orientation Test, is a standardized test of visuospatial skills, 
that measures a person’s ability to match the angle and orientation of lines in 
space.[21] The second, the Hooper Visual Organization Test,[22] is an instrument 
that measures visual organizational skills, and consists of line drawing of simple 
objects that have been cut into pieces and rearranged, such as in a puzzle. The 
examinee’s task is to name what the object would be if the pieces were put back 
together.[22] In both tests, higher scores indicate better cognitive functioning.[21, 
22] 
To evaluate verbal memory, we used the Wechsler Memory Scale-Third 
Edition (WMS-III) Word List,[23] which included four learning trials of 12 unrelated 
words. World List 1 is derived from the sum of the four trials.[23] A second list is 
then presented once for immediate recall, following which the examinee is asked 
to again recall the first list.[23] Free recall and recognition (yes-no format) of the 
initial words are later assessed after a delay interval.[23] Higher scores indicate 
better cognitive functioning.[23] 
To evaluate visual memory, we used the Brief Visuospatial Memory Test-
Revised.[24] In three learning trials, the examinee views the stimulus page and 
is asked to draw as many of the figures as possible.[24] A delayed recall trial is 
administered after a 25-minute delay.[24] Last, there is a recognition trial, in which 
the examinee is asked to identify which of 12 figures were included among the 
original ones.[24] Higher scores indicate better cognitive functioning.[24] 
Language was evaluated using two tests. First, the Boston Naming Test,[25] 
which assesses the ability to name pictures of objects through spontaneous 
responses and the need for various types of cueing (lower scores indicate greater 
cognitive impairment). Second, subjects were asked to name as many different 
animals as they could in 60 seconds (semantic  fluency) (lower scores indicate 
greater cognitive impairment).[26] Depressive symptoms were assessed with the 
17-item version of the Hamilton Depression Rating Scale.[27] Higher scores 
reflect more depressive symptoms.[27] 
Psychopathology and personality symptoms were assessed using the 
Personality Assessment Inventory (PAI), a widely used multidimensional 344-
item self-report measure.[28] The PAI consists of 22 nonoverlapping scales: 4 
validity scales, 11 clinical scales, 5 treatment consideration scales, and 2 
interpersonal scales. For the present study, only clinical scales (somatic 
concerns, anxiety, anxiety related disorders, depression, mania, paranoia, 
schizophrenia, borderline features, antisocial features, alcohol-related problems, 
and drug-related problems) were used, and higher scores reflect greater 
psychopathology.  
We also assessed the impact of neuropsychiatric disturbances on OT 
patients’ health-related quality of life (HRQoL) by means of the Spanish version 
of EuroQol-5 dimension (EQ-5D), a standardised instrument developed by the 
EuroQol group, a consortium of investigators in Europe.[29] The EQ-5D was 
chosen as the generic HRQoL measure given its widespread use and its apparent 
applicability to other tremor disorders such as Parkinson’s disease[30] and 
ET.[31] EQ-5D consists of two parts: the EQ-5D descriptive system and the EQ 
visual analogue scale (EQ VAS).[29] The EQ-5D descriptive system comprises 
five dimensions: mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression.[29] Each dimension has three levels (no problems, some 
problems, major problems) and together results in a numeric value that defines a 
health state. EQ-5D scores range between −0.594 and 1 (full health).[29] The EQ 
VAS records the respondent’s self-rated health on a 20 cm vertical, visual 
analogue scale with endpoints labelled ‘the best health you can imagine’ (100) 
and ‘the worst health you can imagine’ (0).[29] 
According to a recently published comorbidity score developed in 
ambulatory care settings,[32] a comorbidity index was calculated. The presence 
of several items resulted in the assignment of more points than others, and the 
score ranged from 0 – 28 (i.e., all conditions present). [32]  
All procedures were approved by the ethical standards committees on 
human experimentation at the University Hospitals “12 de Octubre” (Madrid) and 




Statistical analyses were performed in SPSS Version 21.0 (IBM Corp., 
NY, USA). All tests were two sided, and significance was accepted at the 5% 
level (alpha = 0.05). Mean scores (age, years of education, age at onset, tremor 
duration, and neuropsychological and personality variables) were compared 
using two independent sample t-tests for continuous and normally distributed 
data, and Mann–Whitney U tests for non-normally distributed data, where 
appropriate. The χ2 test was used to analyze differences in several variables 
(sex and current smoker).  
To assess differences between OT patients and controls in 
neuropsychological and personality scores while adjusting for age, sex, years of 
education, comorbidity index, current smoker, and depressive symptoms, linear 
regression analyses were performed in which the outcome variables were each 
one of the neuropsychological and PAI scores. Using a one-sample 
Kolmogorov-Smirnov test, we tested whether neuropsychological and 
personality scores were normally distributed and, for several scores, a 
logarithmic transformation was performed prior to linear regression analyses.  
 
RESULTS 
Clinical details of the OT patients are provided in Tables 1 and 2. All 16 
OT patients were right-handed and the mean age = 65.7 years (range 37 to 81). 
The mean age of onset was 56.8 years. There was a slight female 
preponderance (N = 12, 75%). All patients presented with unsteadiness that 
occurred within seconds of standing and was relieved by walking or sitting. The 
symptoms of unsteadiness coincided with the appearance of the tremor of the 
trunk and legs. On diagnosis, 9 (56.2%) patients presented with primary OT and 
7 (43.7%) had additional neurological features (mild parkinsonian signs). 
Twelve (75%) patients reported a progressive disease course. Structural brain 
magnetic resonance imaging, or computed tomography imaging, was 
unremarkable in all OT patients; none had cerebellar atrophy. Routine blood 
and chemistry tests including thyroid function tests, serum protein 
electrophoresis, and vitamin B12 levels were also in the normal range in all 
patients. Before formal neuropsychological testing, all 16 OT patients 
underwent electromyographic analysis of their leg tremors. This revealed a 
synchronous 10- to 18-Hertz leg tremor that was present only on standing. No 
patients were being treated with medication for OT (i.e., clonazepam, 
pramipexole, or barbiturates). 
The 16 right-handed OT patients (12 women and 4 men) were compared 
with 32 right-handed healthy controls (19 women and 13 men). The 16 OT 
patients did not differ to a significant degree from the 32 controls in terms of 
age, sex, years of education, comorbidities, current smoking, and depressive 
symptoms (Table 1). The results of neuropsychological testing are shown in 
Table 1. In most domains, OT patients’ cognitive performance was significantly 
worse than that of the healthy controls. These differences involved selected 
tests of executive function, visuospatial ability, verbal memory, visual memory, 
and language (Table 1). Further, OT patients exhibited an altered personality 
profile, with statistically higher mean scores for somatic concerns, anxiety 
related disorders, and depression, as well as borderline and antisocial features 
(Table 1). 
Although OT patients and controls did not differ to a significant degree in 
terms of demographic and clinical features, if the sample size had been larger, 
several of these features could have differed significantly. Hence, we performed 
adjusted analyses to take any potential confounding into account. In linear 
regression analyses that adjusted for age in years, sex, years of education, 
comorbidity index, current smoker, and depressive symptoms, we found that 
diagnosis (OT vs. control) was associated with poor performance on most 
neuropsychological test scores, particularly on tests of attention, executive 
function, visuospatial ability, verbal memory, visual memory, and language, as 
well as with distinct personality profile (higher levels of somatic concerns, 
anxiety related disorders, depression, as well as antisocial features) (Table 3). 
In additional analyses, we excluded OT-plus patients (N = 7) (i.e., those 
associated with mild parkinsonian signs on examination). The results were 
similar (Table 3). Finally, OT patients were stratified into younger onset (onset 
age ≤60 years, N = 8, current age = 57.1 ± 13.4 years) vs. older onset (onset 
age > 60 years, N = 8, current age = 74.4 ± 5.2 years) and, in linear regression 
analyses that adjusted for age in years, sex, years of education, comorbidity 
index, current smoker, and depressive symptoms, we found that OT diagnosis, 
and more so older onset OT, was associated with poor performance on many 
neuropsychological test scores (Table 3).  
 
DISCUSSION 
This study shows that OT patients seem to have cognitive deficits in 
widespread domains, including deficits in executive function, visuospatial ability, 
verbal memory, visual memory, and language. Further, OT patients scored higher 
(i.e., greater psychopathology) on several PAI subscales (somatic concerns, 
anxiety related disorders, depression, and antisocial features). These personality 
characteristics are suggestive of alterations of executive functioning (antisocial 
features) and affective dysfunction (anxiety related disorders and depression). 
Of interest is that older-onset (>60 years) OT patients had poorer 
performance on neuropsychological test scores that those with younger-onset 
OT. Cognitive dysfunction in OT might therefore be influenced by the age at 
onset. In essential tremor as well, the association between older age of onset and 
cognitive impairment has been reported (i.e., in one study, essential tremor 
patients with older age of onset are more likely to be cognitively impaired than 
are essential tremor patients with younger age of onset).[33] 
The biological basis for these neuropsychiatric deficits in OT patients is not 
clear, but the circuitry involved could include the frontosubcortical pathways, 
which play a role in cognitive and affective processes.[34] Conversely, the 
constellation of cognitive and affective changes in OT patients shown here largely 
resembles Schmahmann's syndrome.[35] These authors argued that cognitive 
and affective changes may be related to a cerebellar disorder itself, particularly 
when the posterior lobe is involved, which led them to propose presence of this 
syndrome, characterized by the following features. First, disturbances of 
executive function (this includes deficient planning, set-shifting, abstract 
reasoning, working memory, and decreased verbal fluency); second, impaired 
spatial cognition; third, personality changes; and fourth, linguistic difficulties.[35] 
All these deficits have been attributed to the disruption of the neural circuits 
linking prefrontal, temporal, posterior parietal and limbic cortices with the 
cerebellum.[35] 
The pathophysiology of OT is currently unknown. The observation that 
unilateral transcranial magnetic stimulation of the cortical leg area resets OT in 
both legs, whereas OT is not modified by any peripheral stimuli, supports the 
hypothesis of a unique supraspinal OT generator.[36] Classically, the tremor 
generator has been postulated to be located in the brainstem, since OT motor 
symptoms involve bilateral cranial structures, arms, trunk, and legs.[37] The 
circuitry involving in OT pathogenesis, however, may be complex, with feedback 
and feed forward modulation (i.e., involving several brain regions).[37] There is 
some research suggesting that the dopaminergic system may be involved in 
OT.[3, 4] More specifically, an association with parkinsonism and treatment 
effects of L-dopa and dopamine agonists have been reported.[3, 4, 38] A 
study[38] using (123)I-FP-CIT ([(123)I]-2 beta-carbomethoxy-3beta-(-4-
iodophenyl)-N-(3-fluoropropyl)-nortropane) as a dopamine transporter tracer 
showed a marked reduction in striatal tracer binding in 11 OT patients without 
parkinsonism. Finally, a positron emission tomography study demonstrated 
abnormal bilateral cerebellar and contralateral lentiform and thalamic activation 
in four OT patients.[7] Taken together, these findings suggest that, although the 
OT generator might be located in the brainstem, other brain regions such as the 
motor cortex, basal ganglia, and cerebellum may also be involved.  
We hypothesize that cognitive and motor frontocerebellar circuits function 
abnormally in OT. It is worth noting how the observed OT-related 
neuropsychological deficits resemble those reported in the literature to occur after 
isolated cerebellar lesions. First, our patients experienced cognitive difficulties 
impacting executive functions (including working memory) and frontal lobe tasks 
and similarly, several reports of cerebellar patients have also noted impaired 
executive function.[39] For example, working memory, a cognitive process that 
can be considered an example of a test of executive function, has been 
consistently shown to strongly engage cerebellar circuits,[40] suggesting that the 
role of the cerebellum in working memory includes aspects of encoding, 
maintenance, and retrieval.[41] Second, the observed fluency deficits among OT 
patients also parallel those reported after cerebellar lesions.[35] Finally, given 
that the posterior parietal cortex receives afferent connections from cerebellum 
via the pons and thalamus,[42] the poor performance in visuospatial functions 
among OT patients may reflect the involvement of the cerebello-ponto-thalamo-
parietal pathways. On-going research in resting-state functional MRI and 
diffusion tensor imaging in OT will provide valuable new insights into the clinical 
nature of OT and its underlying pathophysiology. 
The study was not without limitations. First, the sample size was relatively 
small. The OT literature, however, only includes studies with small sample sizes. 
One should keep in mind that OT is a very rare disease and hence it is rather 
difficult to recruit patients. Although there are no available epidemiological data, 
in the follow-up evaluation of the Neurological Disorders of Central Spain 
(NEDICES) study,[43] we detected only one patient with OT in a cohort of 
approximately 4,000 elderly subjects (data not published). Despite the small 
sample size, our sample was adequate to detect a number of robust differences 
between the two study groups. Second, the patients in the current study may 
represent a selected group of OT patients (i.e., patients seen in selected 
outpatient clinics), and hence it is questionable to what extent our results can be 
generalized to the entire OT population. However, in Spain, healthcare is fully 
state-subsidized, and community-dwelling OT patients are mostly seen by 
hospital-based and hospital-associated neurologists. Third, the recruited sample 
was quite heterogeneous, including primary OT cases and OT-plus cases. 
However, our aim was to examine whether OT patients in general had cognitive 
deficits when compared with matched controls. Further, after exclusion of OT-
plus cases, the results remained similar. This study also had several strengths. 
First, this is the first study that has assessed the cognitive and personality profile 
of OT patients. Second, assessments were conducted prospectively in a 
standardized manner. Finally, the tests included are reported to be amongst the 
most sensitive neuropsychological measures to detect cognitive impairment in 
other tremor disorders.[10, 11]  
In conclusion, OT patients seem to have deficits in specific aspects of 
neuropsychological functioning, particularly those thought to rely on the integrity 
of the prefrontal cortex, which suggests involvement of frontocerebellar circuits. 
We suggest that cognitive impairment and personality disturbances may be 
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Table 1: Comparison of demographic, clinical and neuropsychiatric domains of 





(N = 16) 
Healthy controls 
(N = 32) 
p value 
Age in years 65.7 (66.9) ± 13.3 67.8 (70.0) ± 11.1 0.564 a 
Sex (female) 12 (75.0%) 19 (59.4%) 0.286 
Education in years 7.8 (8.0) ± 4.7 8.6 (8.0) ± 3.3 0.505 a 
Comorbidity index* 1.4 (0.0) ±1.8 1.0 (0.0) ± 2.2 0.104b 
Current smoker 2 (12.5%) 1 (3.1%) 0.206 
Depressive symptoms    
17-item Hamilton Depression Rating Scale total 
score[27] 
8.1 (6.5) ± 6.9 5.8 (5.0) ± 5.2 0.205a 
Age at onset, years 56.8 (60.5) ± 12.2 -  
Tremor duration, years 8.9 (6.8) ± 6.6 -  
EuroQol-5D index score 0.7 (0.7) ± 0.2 -  
EuroQol visual analogue scale 66.6 (77.5) ± 25.0   
Cognitive domains    
Attention     
Direct Digit Span subtest from the WAIS-III[15] 5.2 (5.0) ± 1.4 5.6  (6.0) ± 1.3 0.245a 
Coding-Digit Symbol subtest from the WAIS-III[15] 35.3 (21.0) ± 30.4 45.6 (45.0) ± 17.1 0.252a 
Executive function    
Stroop Color–Word Trial[16] 23.3 (19.5) ± 13.2 30.0 (31.5) ± 10.6 0.079a 
Wisconsin Card Sorting Test[17]    
  Perseverations 32.0 (24.0) ± 27.9 38.0 (32.0) ± 26.3 0.481a 
  Non-perseverative errors 67.6 (69.0) ± 24.8 59.2 (59.5) ± 23.7 0.269a 
Similarities subtest from the WAIS-III[15] 10.7 (9.0) ± 5.0 17.3 (17.0) ± 5.4 0.0001a 
Indirect Digit Span subtest from the WAIS-III [15] 3.2 (3.0) ± 1.3 4.3  (4.0) ± 1.0 0.002a 
Controlled Oral Word Association Test[18]  24.9 (22.0) ± 20.6 37.2 (39.0) ± 13.8 0.018a 
Tower of London (time of execution in 
seconds)[19] 
570.2 (602.5) ± 292.2 370.3 (320.5) ± 169.9 0.020a 
Frontal Battery Assessment[20] 14.3 (15.0) ± 3.0 17.0 (17.0) ± 1.0 <0.001b 
Visuospatial ability    
Benton Judgment of Line Orientation Test[21] 8.6 (9.5) ± 3.0 10.0 (10.0) ± 2.5 0.100a 
Hooper Visual Organization Test[22] 26.3 (29.0) ± 14.7 36.5 (36.0) ± 9.4 0.023a 
Verbal memory    
WMS-III Word List[23]    
  Learning trials total 25.1 (22.5) ± 7.4 28.0 (27.5) ± 5.8 0.150a 
  Immediate recall 4.9 (4.5) ± 2.3 6.5 (6.0) ± 2.2 0.023a 
  Delayed recall 4.5 (4.0) ± 2.7 6.2 (6.0) ± 2.4 0.034a 
  Recognition 19.8 (20.5) ± 3.7 22.1 (22.0) ± 1.4 0.028b 
Visual memory    
Brief Visuospatial Memory Test-Revised[24]    
  Learning trials 14.8 (10.5) ± 11.5 27.7 (30.5) ± 8.0 0.002a 
  Delayed recall trial 5.1 (4.5) ± 4.7 10.0 (10.0) ± 2.1 0.001b 
  Recognition trial 11.6 (12.0) ± 0.8 11.7 (12.0) ± 0.6 0.497b 
Language    
Boston Naming Test[25] 40.8 (37.0) ± 10.5 52.3 (53.5) ± 5.2 0.001a 
Total number of animals as possible in one 
minute[26] 
15.2 (13.0) ± 7.4 20.7 (19.5) ± 6.5 0.011a 
Personality and Psychopathology    
Personality Assessment Inventory[28]    
Somatic concerns 15.6 (14.0) ± 7.0 8.1 (7.0) ± 5.5 <0.001a 
Anxiety 10.8 (13.0) ± 7.6 6.5 (6.0) ± 5.0 0.060a 
Anxiety related disorders 16.4 (13.0) ± 7.2 11.4 (11.0) ± 5.3 0.028a 
Depression 12.5 (10.0) ± 8.0   5.9 (5.0) ± 4.5 0.009a 
Mania 8.0 (7.0) ± 5.9 6.8 (6.0) ± 4.4 0.458a 
Paranoia 12.1 (11.0) ± 7.8 9.5 (10.0) ± 4.2 0.254a 
Schizophrenia 7.5 (8.0) ± 5.0 5.2 (4.0) ± 3.2 0.133a 
Borderline features 9.5 (8.0) ± 5.3 6.5 (7.0) ± 4.1 0.048a 
Antisocial features 3.4 (3.0) ± 2.1 2.0 (2.0) ± 1.7 0.023a 
Alcohol problems 0.5 (0.0) ± 1.5 0.1 (0.0) ± 0.6 0.223b 
Drug problems 0.5 (0.0) ± 1.1 0.4 (0.0) ± 1.0 0.796b 
Mean (median) ± SD and frequency (%) are reported. aStudent’s t tests or bMann-Whitney U 
test were used for comparisons of continuous data, and X2 test for sex, and current smoker. 
*Comorbidity included 13 conditions: atrial fibrillation, nonmetastatic cancer, metastatic cancer, 
chronic obstructive pulmonary disease, depression, dementia, diabetes, epilepsy (treated), 
heart failure, myocardial infarction, psychiatric disorders, renal disease, and stroke. 
WAIS-III = Wechsler Adult Intelligence Scale-Third Edition. 
WMS-III = Wechsler Memory Scale-Third Edition. 




Table 2: Demographic and clinical characteristics of orthostatic tremor patients. 
Age (years) Sex Age at onset (years) Associated neurological features Tremor frequency in lower limbs* 
74 Female 67 None 16-18 Hertz 
64 Female 55 None 10-12 Hertz 
57 Male 54 None 16-18 Hertz 
68 Female 62 Mild parkinsonian signs 16-18 Hertz 
57 Female 51 None 16-18 Hertz 
78 Female 64 Mild parkinsonian signs 16-18 Hertz 
62 Female 60 Postural upper limb tremor on arm extension 12-16 Hertz 
37 Female 34 None 16-18 Hertz 
76 Female 50 Postural upper limb tremor on arm extension 12-16 Hertz 
75 Female 62 Mild parkinsonian signs 12-16 Hertz 
77 Female 68 Mild parkinsonian signs 12-16 Hertz 
77 Male 70 Mild parkinsonian signs 12-16 Hertz 
38 Male 17 Postural upper limb tremor on arm extension 16-18 Hertz 
65 Male 61 Mild parkinsonian signs 10-12 Hertz 
81 Female 74 Mild parkinsonian signs 12-16 Hertz 
65 Female 60 None 16-18 Hertz 
 
*Assessed with electromyography.
Table 3: Linear regression analyses using each neuropsychological test score as the outcome variable in separate adjusted 
models. 
 








 Outcome variable *  Beta p value 
 
Beta p value 
 
Beta p value 
 
Beta p value 
 
Attention  Direct Digit Span test from the WAIS-III[15] -0.059 0.691 0.057 0.738 0.038 0.829 -0.194 0.285 
 Coding-Digit Symbol subtest from the 
WAIS-III[15] 
-0.180 0.075 -0.097 0.403 -0.083 0.487 -0.324 0.008 
          
Executive 
Function 
Stroop Color–Word Trial[16] -0.185 0.169 -0.096 0.531 -0.090 0.573 -0.293 0.082 
 Wisconsin Card Sorting Test[17]         
   Perseverations -0.147 0.358 -0.105 0.526 -0.048 0.777 -0.169 0.369 
   Non-perseverative errors 0.136 0.333 0.124 0.442 0.150 0.370 0.109 0.496 
 Similarities subtest from the WAIS-III[15] -0.490 <0.001 -0.459 0.002 -0.431 0.005 -0.468 0.002 
 Indirect Digit Span subtest from the WAIS-
III[15] 
-0.350 0.010 -0.296 0.063 -0.319 0.052 -0.368 0.029 
 Controlled Oral Word Association Test[18]  -0.252 0.065 -0.179 0.250 -0.206 0.197 -0.329 0.053 
 Tower of London (time of execution in 
seconds) [19] 
0.429 0.002 0.316 0.040 0.298 0.065 0.547 <0.001 
 Frontal Assessment Battery[20] -0.439 0.001 -0.407 0.009 -0.455 0.004 -0.526 0.001 
          
Visuospatial ability Benton Judgment of Line Orientation 
Test[21] 
-0.136 0.277 -0.118 0.373 -0.127 0.354 -0.131 0.392 
 Hooper Visual Organization Test[22] -0.386 0.001 -0.276 0.025 -0.292 0.022 -0.473 0.001 
          
Verbal memory WMS-III Word List[23]         
   Learning list -0.221 0.069 -0.119 0.377 -0.074 0.596 -0.393 0.009 
   Immediate recall -0.366 0.009 -0.348 0.027 -0.341 0.037 -0.313 0.049 
   Delayed recall -0.322 0.007 -0.308 0.020 -0.264 0.055 -0.332 0.019 
   Recognition -0.396 0.006 -0.452 0.005 -0.332 0.047 -0.498 0.003 
          
Visual memory Brief Visuospatial Memory Test-Revised[24]         
   Learning trials total -0.351 0.007 -0.301 0.116 -0.282 0.166 -0.533 0.005 
   Delayed free recall trial -0.534 <0.001 -0.440 0.006 -0.431 0.010 -0.679 <0.001 
   Recognition trial -0.082 0.586 -0.075 0.652 -0.018 0.918 -0.146 0.415 
          
Language Boston Naming Test[25] -0.574 <0.001 -0.535 <0.001 -0.598 <0.001 -0.601 <0.001 
 Total number of animals as possible in one 
minute[26] 
-0.347 0.006 -0.281 0.059 -0.259 0.092 -0.352 0.012 
Personality and 
Psychopathology 
Personality Assessment Inventory[28]         
   Somatic concerns 0.479 0.001 0.390 0.020 0.398 0.021 0.543 0.003 
   Anxiety 0.260 0.057 0.099 0.504 0.171 0.253 0.345 0.033 
   Anxiety related disorders 0.412 0.002 0.295 0.044 0.297 0.050 0.487 0.002 
   Depression 0.440 0.001 0.259 0.078 0.218 0.156 0.560 <0.001 
   Mania 0.210 0.168 0.087 0.594 0.006 0.970 0.409 0.024 
   Paranoia 0.266 0.098 0.058 0.741 0.078 0.669 0.385 0.029 
   Schizophrenia 0.282 0.058 0.161 0.323 0.143 0.400 0.351 0.054 
   Borderline features 0.255 0.079 0.107 0.462 0.003 0.985 0.399 0.016 
   Antisocial features 0.348 0.021 0.172 0.225 0.126 0.382 0.505 0.007 
   Alcohol problems 0.264 0.122 0.304 0.100 0.318 0.095 -0.033 0.875 
   Drug problems 0.020 0.894 0.095 0.547 0.114 0.485 -0.119 0.503 
 
* Adjusted for age, sex, years of education, comorbidity index, current smoker, and depressive symptoms. Significant values are in 
bold font. 
 
